Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use SANCUSO safely and effectively. See full prescribing information for SANCUSO. SANCUSO (granisetron transdermal system) Initial U.S. Approval: 2008
Medication labelWhy this: Advisory · dailymed-prescription
SANCUSO® is indicated for the prevention of nausea and vomiting in adults receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration.
- generic_name
- granisetron
- product_names
- granisetron
- ndc
- 66220-637, 66220-637-31, 66220-637-72
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en